Literature DB >> 21768802

Empiric antimicrobial therapy for Gram-negative sepsis: back to the future.

Surbhi Leekha, Harold C Standiford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21768802     DOI: 10.1097/CCM.0b013e318223b94b

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  3 in total

1.  In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia.

Authors:  Min Kyeong Cha; Cheol-In Kang; So Hyun Kim; Sun Young Cho; Young Eun Ha; Yu Mi Wi; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

Review 2.  The clinical impact of multidrug-resistant gram-negative bacilli in the management of septic shock.

Authors:  Aurora Pop-Vicas; Steven M Opal
Journal:  Virulence       Date:  2013-08-27       Impact factor: 5.882

Review 3.  Prognostic Value of Red Blood Cell Distribution Width in Non-Cardiovascular Critically or Acutely Patients: A Systematic Review.

Authors:  Rubin Luo; Jian Hu; Libing Jiang; Mao Zhang
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.